|
시장보고서
상품코드
2051265
콜레라 백신 시장 : 제품 유형별, 백신 유형별, 환자 유형별, 유통 채널별, 지역별Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography |
||||||
세계의 콜레라 백신 시장은 2026년에 9,290만 달러로 추정되고, 2033년까지 2억 1,070만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 12.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 9,290만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.40% | 2033년 시장 규모 예측 : | 2억 1,070만 달러 |
콜레라는 보통 오염된 물을 통해 감염되는 세균성 질환입니다. 심한 설사와 탈수 증상을 유발하고, 치료를 받지 않으면 몇 시간 내에 사망에 이를 수도 있습니다. 이 질병은 아프리카, 동남아시아, 아이티 등 수처리가 불충분하고 위생 환경과 위생 습관이 열악한 지역에서 가장 많이 발생합니다. 세계보건기구(WHO)와 유엔아동기금(UNICEF)은 콜레라가 치명적인 속도로 재유행하고 있으며, 특히 취약한 지역사회를 표적으로 삼고 있다고 경고했습니다. 빈곤, 전쟁 또는 자연재해로 인해 사람들이 적절한 위생 환경 없이 과밀하게 생활할 수밖에 없는 상황에서 콜레라 대유행의 위험은 가장 높아집니다. 콜레라는 빈곤으로 인한 질병으로, 안전한 물과 기본적인 위생 시설에 대한 접근성이 부족한 사람들에게 영향을 미칩니다. 이 감염병은 사람 간 직접 감염 가능성이 낮기 때문에 감염자와의 우연한 접촉이 질병에 걸릴 큰 위험 요인이 되지는 않습니다. 예방의 관점에서 볼 때, 콜레라를 억제하고 사망자 수를 줄이기 위해서는 다각적인 접근이 관건입니다. 여기에는 안전한 물에 대한 접근성, 적절한 위생 시설, 위생 관리, 고위험 지역에서의 백신 접종 등이 포함됩니다.
시장 역학
세계 콜레라 백신 시장의 성장을 이끄는 주요 요인으로는 세계 콜레라 질병 부담 증가, 콜레라 유행 예방에 대한 관심 증가, 장기적인 예방 효과가 있는 새로운 경구용 백신의 개발 등이 있습니다. 그러나 저소득 지역의 백신 접근성 부족, 특정 지역사회의 예방접종에 대한 인식 부족 등의 요인이 시장의 잠재력을 어느 정도 억제하고 있습니다. 밝은 재료로, 여러 혈청형에 대한 교차 면역을 제공하는 백신 연구에 대한 투자가 증가하고 있으며, 새로운 길이 열리고 있습니다. 또한, 전염병이 유행하는 지역에서 공급을 개선하기 위해 제조업체와 국제기구와의 협력은 향후 몇 년 동안 매력적인 기회를 가져올 것입니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 콜레라 백신 시장의 주요 기업 프로파일을 작성했습니다. 여기에는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략이 포함됩니다. 주요 기업으로는 Sanofi, Biovac.co.za, EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co. Co., Ltd(Hillhouse Capital), PaxVax, Inc., Astellas Pharmaceuticals, EUBIOLOGICS CO., LTD.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 콜레라 백신 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 콜레라 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 콜레라 백신 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 콜레라 백신 시장 : 백신 유형별, 2021년-2033년
제6장 세계의 콜레라 백신 시장 : 환자 유형별, 2021년-2033년
제7장 세계의 콜레라 백신 시장 : 유통 채널별, 2021년-2033년
제8장 세계의 콜레라 백신 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.18Global Cholera Vaccines Market is estimated to be valued at USD 92.9 Mn in 2026 and is expected to reach USD 210.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 92.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.40% | 2033 Value Projection: | USD 210.7 Mn |
Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.
Market Dynamics
Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021 - 2033)
- Vaxchora
- Dukoral
- ShanChol
- Euvichol-Plus/Euvichol
- Others (Late Phase Vaccines, etc.)
- By Vaccine Type (Revenue, USD Mn, 2021 - 2033)
- Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Killed Whole-cell Only Vaccines
- Live Attenuated Oral Cholera Vaccine
- By Patient Type (Revenue, USD Mn, 2021 - 2033)
- Pediatric
- Adults
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Public
- Private
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Cholera Vaccines Market
- Sanofi
- Biovac.co.za.
- EMERGENT
- Celldex Therapeutics
- Valneva SE
- Hilleman Laboratories
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
- PaxVax, Inc.
- Astellas Pharma Inc.
- EUBIOLOGICS CO., LTD.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Vaccine Type
- Market Snippet, By Patient Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing Vaccination Campaigns
- Supply Shortage of Cholera Vaccine
- Increasing Educational Training Programmes
- Key Highlights
- Regulatory Scenario
- Market Trends
- Pipeline Analysis
- Product Launch/Approval
- PEST Analysis
- PORTER's Analysis
- Epidemiology
- Treatment Algorithm (Patient Journey)
- Treatment Option Analysis
- New Investments by Major Market Players
- Pricing Analysis
- Disease Awareness Programs
- Treatment Safety and Efficacy Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Cholera Vaccines Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Vaxchora
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Dukoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- ShanChol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Euvichol-Plus/Euvichol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others (Late Phase Vaccines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Cholera Vaccines Market, By Vaccine Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Killed Whole-cell Only Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Live Attenuated Oral Cholera Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Cholera Vaccines Market, By Patient Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Cholera Vaccines Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 201s9-2033,(US$ Mn)
8. Global Cholera Vaccines Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profile
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biovac.co.za.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- EMERGENT
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Celldex Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Valneva SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hilleman Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- EUBIOLOGICS CO., LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Analyst Views
10. Section
- References
- Research Methodology
- About us
